A prospective clinical study of peripheral CD177+ neutrophils and prognosis in acute ischemic stroke

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035674

Enrollment

Unknown

Registered

2020-08-16

Start date

2020-08-15

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 85 years old; 2. the diagnosis of ischemic stroke confirmed by computed tomography or magnetic resonance imaging within 24 hours after the onset of neurological impairment symptoms; 3. get informed consent and voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1. Previous history of stroke, brain injury, Alzheimer's disease, Parkinson's disease and other neurological diseases; 2. signs of infection before admission or within 72 hours after admission; 3. History of tumor or autoimmune disease; 4. Use of glucocorticoids or other immunosuppressive drugs; 5. Have a history of hospitalization or surgery within 30 days before admission.

Design outcomes

Primary

Measure	Time frame
CD177+ neutrophil count in peripheral blood;	—

Countries

China

Contacts

Public ContactZhu Huichen

Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine

1847437955@qq.com+86 13916741712

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026